中国处方药
中國處方藥
중국처방약
Journal Of China Prescription Drug
2015年
10期
3-4
,共2页
心脑宁胶囊%不稳定性心绞痛%临床研究%心血管易损因子
心腦寧膠囊%不穩定性心絞痛%臨床研究%心血管易損因子
심뇌저효낭%불은정성심교통%림상연구%심혈관역손인자
Xinnaoning Capsule%Unstable angina pectoris%Clinical study%Cardiovascular vulnerability factors
目的 探讨心脑宁胶囊治疗冠心病不稳定性心绞痛患者的临床疗效.方法 70例患者随机分为心脑宁组(n=36)及对照组(n=34),对照组仅予常规西药治疗,心脑宁组采用常规西药加心脑宁胶囊治疗,用药30 d后,观察治疗前后临床症状、心绞痛发作、心电图的ST-T改变,检测超敏C反应蛋白、同型半胱氨酸等.结果 心脑宁组在自觉症状、心绞痛发作次数与持续时间、心电图改善,以及降低超敏C反应蛋白、同型半胱氨酸水平方面均优于对照组,差异有统计学意义(P<0.05).结论 心脑宁胶囊是治疗冠心病不稳定性心绞痛的安全、有效药物.
目的 探討心腦寧膠囊治療冠心病不穩定性心絞痛患者的臨床療效.方法 70例患者隨機分為心腦寧組(n=36)及對照組(n=34),對照組僅予常規西藥治療,心腦寧組採用常規西藥加心腦寧膠囊治療,用藥30 d後,觀察治療前後臨床癥狀、心絞痛髮作、心電圖的ST-T改變,檢測超敏C反應蛋白、同型半胱氨痠等.結果 心腦寧組在自覺癥狀、心絞痛髮作次數與持續時間、心電圖改善,以及降低超敏C反應蛋白、同型半胱氨痠水平方麵均優于對照組,差異有統計學意義(P<0.05).結論 心腦寧膠囊是治療冠心病不穩定性心絞痛的安全、有效藥物.
목적 탐토심뇌저효낭치료관심병불은정성심교통환자적림상료효.방법 70례환자수궤분위심뇌저조(n=36)급대조조(n=34),대조조부여상규서약치료,심뇌저조채용상규서약가심뇌저효낭치료,용약30 d후,관찰치료전후림상증상、심교통발작、심전도적ST-T개변,검측초민C반응단백、동형반광안산등.결과 심뇌저조재자각증상、심교통발작차수여지속시간、심전도개선,이급강저초민C반응단백、동형반광안산수평방면균우우대조조,차이유통계학의의(P<0.05).결론 심뇌저효낭시치료관심병불은정성심교통적안전、유효약물.
Objective To study the clinical effects of Xinnaoning Capsule in the treatment of unstable angina pectoris with coronary heart diseases of patients.Methods 70 CHD patients were randomly divided into Xinnaoning group(n=36) and control group(n=34), Patients in control group were treated 0nly by routine therapy,while Patients in Xinnaoning group received conventional therapy plus Xinnaoning Capsule for 30days. The clinical symptoms,angina stenosis,electrocardiogram were observed and high sensitivity C-Reactive Protein(hs-CRP),Homocysteine(Hcy)were detected before and after treatment.Results Compared with the control group,Xinnaoning group had a much better improvement in clinical symptoms,angina stenosis, electrocardiogram and level of hs-CRP,Hcy(P<0.05).Conclusion Xinnaoning Capsule has a good therapeutic efficacy and safety for unstable angina pectoris with coronary heart diseases of patients.
